Stryker EBITDA 2010-2025 | SYK

Stryker annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Stryker EBITDA for the quarter ending March 31, 2025 was $1.109B, a 9.98% decline year-over-year.
  • Stryker EBITDA for the twelve months ending March 31, 2025 was $4.616B, a 10.47% decline year-over-year.
  • Stryker 2024 annual EBITDA was $4.739B, a 3.6% decline from 2023.
  • Stryker 2023 annual EBITDA was $4.916B, a 28.05% increase from 2022.
  • Stryker 2022 annual EBITDA was $3.839B, a 7.41% increase from 2021.
Stryker Annual EBITDA
(Millions of US $)
2024 $4,739
2023 $4,916
2022 $3,839
2021 $3,574
2020 $3,035
2019 $3,491
2018 $3,260
2017 $2,939
2016 $2,721
2015 $2,258
2014 $1,624
2013 $1,563
2012 $2,018
2011 $1,846
2010 $1,916
2009 $1,979
Stryker Quarterly EBITDA
(Millions of US $)
2025-03-31 $1,109
2024-12-31 $845
2024-09-30 $1,353
2024-06-30 $1,309
2024-03-31 $1,232
2023-12-31 $1,507
2023-09-30 $1,193
2023-06-30 $1,224
2023-03-31 $992
2022-12-31 $1,067
2022-09-30 $1,058
2022-06-30 $1,025
2022-03-31 $689
2021-12-31 $1,057
2021-09-30 $809
2021-06-30 $973
2021-03-31 $735
2020-12-31 $972
2020-09-30 $1,057
2020-06-30 $173
2020-03-31 $833
2019-12-31 $1,139
2019-09-30 $822
2019-06-30 $812
2019-03-31 $718
2018-12-31 $874
2018-09-30 $761
2018-06-30 $858
2018-03-31 $767
2017-12-31 $883
2017-09-30 $688
2017-06-30 $662
2017-03-31 $706
2016-12-31 $821
2016-09-30 $634
2016-06-30 $645
2016-03-31 $621
2015-12-31 $756
2015-09-30 $479
2015-06-30 $523
2015-03-31 $500
2014-12-31 $564
2014-09-30 $547
2014-06-30 $291
2014-03-31 $222
2013-12-31 $512
2013-09-30 $226
2013-06-30 $401
2013-03-31 $424
2012-12-31 $532
2012-09-30 $488
2012-06-30 $452
2012-03-31 $546
2011-12-31 $219
2011-09-30 $568
2011-06-30 $521
2011-03-31 $538
2010-12-31 $252
2010-09-30 $572
2010-06-30 $547
2010-03-31 $546
2009-12-31 $618
2009-09-30 $500
2009-06-30 $390
2009-03-31 $471
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $145.427B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.634B 27.97
Boston Scientific (BSX) United States $152.531B 38.19
EssilorLuxottica (ESLOY) France $127.535B 0.00
Medtronic (MDT) Ireland $109.709B 15.55
Haleon (HLN) United Kingdom $49.754B 28.33
Lonza Group Ag (LZAGY) Switzerland $49.468B 0.00
ResMed (RMD) United States $36.224B 27.21
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Agilent Technologies (A) United States $32.148B 20.88
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.748B 89.29
Koninklijke Philips (PHG) Netherlands $21.431B 15.40
Zimmer Biomet Holdings (ZBH) United States $18.172B 11.67
Baxter (BAX) United States $15.441B 11.53
Smith & Nephew SNATS (SNN) United Kingdom $12.754B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.002B 20.89
Lantheus Holdings (LNTH) United States $5.375B 13.56
Prestige Consumer Healthcare (PBH) United States $4.194B 18.74
Perrigo (PRGO) Ireland $3.646B 9.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.213B 23.69
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.048B 14.09
LeMaitre Vascular (LMAT) United States $1.872B 41.85
AtriCure (ATRC) United States $1.719B 0.00
Neogen (NEOG) United States $1.302B 16.67
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.110B 24.97
BioLife Solutions (BLFS) United States $1.016B 0.00
Kestra Medical Technologies (KMTS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.986B 12.60
InMode (INMD) Israel $0.930B 9.37
Evolus (EOLS) United States $0.642B 0.00
CeriBell (CBLL) United States $0.612B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.519B 0.00
Owens & Minor (OMI) United States $0.517B 4.29
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Surmodics (SRDX) United States $0.422B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.326B 11.98
Aurora Cannabis (ACB) Canada $0.302B 53.70
Cresco Labs (CRLBF) United States $0.277B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.63
Sanara MedTech (SMTI) United States $0.259B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanuwave Health (SNWV) United States $0.242B 0.00
Canopy Growth (CGC) Canada $0.222B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Verano Holdings (VRNOF) United States $0.216B 0.00
Quanterix (QTRX) United States $0.211B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Biote (BTMD) United States $0.194B 5.46
Brainsway (BWAY) Israel $0.192B 50.95
High Tide (HITI) Canada $0.185B 0.00
Omeros (OMER) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.81
Organigram Global (OGI) Canada $0.178B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.135B 16.58
Jin Medical (ZJYL) China $0.122B 0.00
TerrAscend (TSNDF) Canada $0.098B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Veru (VERU) United States $0.090B 0.00
Fonar (FONR) United States $0.090B 11.62
Agape ATP (ATPC) $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
InterCure (INCR) Israel $0.070B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.037B 12.94
Nephros (NEPH) United States $0.035B 46.71
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00